nach oben

Erschienen in:

01.10.2010 | Review Article

A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses

verfasst von: Tim Luckett, Phyllis N Butow, Madeleine T King, Mayumi Oguchi, Gaynor Heading, Nadine A Hackl, Nicole Rankin, Melanie A Price

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of this paper is to inform choice of optimal patient-reported outcome measures (PROMs) of anxiety, depression and general distress for studies evaluating psychosocial interventions for English-speaking adults with heterogenous cancer diagnoses.

Methods

A systematic review was conducted to identify all PROMs used to assess anxiety, depression and general distress in randomised controlled trials (RCTs) of psychosocial interventions for people with cancer published between 1999 and May 2009. Candidate PROMs were evaluated for content, evidence of reliability and validity, clinical meaningfulness, comparison data, efficiency, ease of administration, cognitive burden and track record in identifying treatment effects in RCTs of psychosocial interventions. Property ratings were weighted and summed to give an overall score out of 100.

Results

The Hospital Anxiety and Depression Scale (HADS) scored highest overall (weighted score = 77.5), followed by the unofficial short-form of the Profile of Mood States (POMS), the POMS-37 (weighted score = 60), and the Centre for Epidemiological Studies Depression Scale (CES-D) and original POMS (weighted score = 55 each).

Conclusions

The HADS’ efficiency and substantial track record recommend its use where anxiety, mixed affective disorders or general distress are outcomes of interest. However, continuing controversy concerning the HADS depression scale cautions against dependence where depressive disorders are of primary interest. Where cost is a concern, the POMS-37 is recommended to measure anxiety or mixed affective disorders but does not offer a suitable index of general distress and, like the HADS, emphasises anhedonia in measuring depression. Where depression is the sole focus, the CES-D is recommended.

Love A. (2004). The identification of psychological distress in women with breast cancer. Sydney; available online at http://www.nbocc.org.au/resources/documents/IPD_The_identification_of_psychological_distress_in_women_with_breast_cancer.pdf: National Breast Cancer Centre.

Coyne JC, Lepore SJ, Palmer SC (2006) Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med 32:104–110 [see comment][comment]PubMedCrossRef

Gottlied BH, Wachala ED (2007) Cancer support groups: a critical review of empirical studies. Psycho-oncol 16:379–400CrossRef

Graves KD (2003) Social cognitive theory and cancer patients' quality of life: a meta-analysis of psychosocial intervention components. Health Psychol 22:210–219PubMedCrossRef

Lepore SJ, Coyne JC (2006) Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med 32:85–92 [see comment]PubMedCrossRef

Luebbert K, Dahme B, Hasenbring M (2001) The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psycho-oncol 10:490–502CrossRef

Owen JE, Klapow JC, Hicken B, Tucker DC (2001) Psychosocial interventions for cancer: review and analysis using a three-tiered outcomes model. Psycho-oncol 10:218–230CrossRef

Rajasekaran M, Edmonds P, Higginson I (2005) Systematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients. Palliat Med 19:418–426PubMedCrossRef

Redd WH, Montgomery GH, DuHamel KN (2001) Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 93:810–823PubMedCrossRef

10.

Rehse B, Pukrop R (2003) Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient educ couns 50:179–186PubMed

11.

Roffe L, Schmidt K, Ernst E, Roffe L, Schmidt K, Ernst E (2005) A systematic review of guided imagery as an adjuvant cancer therapy. Psycho-oncol 14:607–617CrossRef

12.

Semple CJ, Sullivan K, Dunwoody L, Kernohan WG (2004) Psychosocial interventions for patients with head and neck cancer: past, present, and future. Cancer Nurs 27:434–441PubMedCrossRef

13.

Van Kuiken D (2004) A meta-analysis of the effect of guided imagery practice on outcomes. J Holist Nurs 22:164–179PubMedCrossRef

14.

Jacobsen PB, Jim HS (2008) Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA: A Cancer Journal for Clinicians 58:214–230CrossRef

15.

Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RKS et al (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15:123–136PubMedCrossRef

16.

Williams S, Dale J (2006) The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 94:372–390PubMedCrossRef

17.

Osborn RL, Demoncada AC, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36:13–34PubMedCrossRef

18.

Uitterhoeve RJ, Vernooy M, Litjens M, Potting K, Bensing J, De Mulder P et al (2004) Psychosocial interventions for patients with advanced cancer—a systematic review of the literature. Br J Cancer 91:1050–1062PubMed

19.

Newell SA, Sanson-Fisher RW, Savolainen NJ (2002) Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst 94:558–584PubMed

20.

Love A (2004) The identification of psychological distress in women with breast cancer. The National Breast Cancer Centre.

21.

Hersch J, Juraskova I, Price M, Mullen B (2009) Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review. Psychooncology 18:795–810PubMedCrossRef

22.

Smith JE, Richardson J, Hoffman C, Pilkington K (2005) Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. JAN Journal of Advanced Nursing 52:315–327CrossRef

23.

National Comprehensive Cancer Network (NCCN). (2007). NCCN Clinical Practice Guidelines in Oncology: Distress Management, from http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf

24.

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, Fourth editionth edn. American Psychiatric, Washington DC, text revised (DSM-IV-TR)

25.

Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DLet al. (2006) Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments. BMC Medical Research Methodology 6: doi: 10.1186/1471-2288-1186-1182.

26.

Sansoni J, Marosszeky N, Jeon Y-H, Chenoweth L, Hawthorne G, King M et al (2007) Final report: dementia outcomes measurement suite project. University of Wollongong, Wollongong

27.

Physiotherapy Evidence Database (PEDro). (1999). The PEDro Scale. Retrieved 13th June 2009, from http://www.pedro.org.au/scale_item.html

28.

King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5:555–567PubMedCrossRef

29.

Luckett T, King MT, Butow PN, Friedlander M, Paris T (2010) Assessing health-related quality of life in gynecological oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer 20:664–684PubMed

30.

King MT, Stockler MS, Cella D, Osoba D, Eton D, Thompson J et al (2010) Meta-analysis provides evidence-based effect sizes for a cancer-specific quality of life questionnaire, the FACT-G. J Clin Epidemiol 63:270–281PubMedCrossRef

31.

Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Lawrence Erlbaum, Hillsdale

32.

Snaith RP, Zigmond AS (1994) The Hospital Anxiety and Depression Scale: manual. GL Assessment, London

33.

Lloyd-Williams M, Friedman T, Rudd N (2001) An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. Journal of Pain & Symptom Management 22:990–996CrossRef

34.

Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G (2004) Screening for depression in head and neck cancer. Psycho-oncol 13:269–280CrossRef

35.

Chaturvedi S (1991) Clinical irrelevance of HADS factor structure: comment. Br J Psychiatry 159:298PubMedCrossRef

36.

Smith AB, Wright EP, Rush R, Stark DP, Velikova G, Selby PJ (2006) Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psycho-oncol 15:817–827CrossRef

37.

Le Fevre P, Devereux J, Smith S, Lawrie SM, Cornbleet M (1999) Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 13:399–407PubMedCrossRef

38.

Pallant JF, Tennant A (2007) An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 46:1–18PubMedCrossRef

39.

Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R et al (1991) The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 158:255–259 [see comment]PubMedCrossRef

40.

Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579–584PubMedCrossRef

41.

Rodgers J, Martin CR, Morse RC, Kendell K, Verrill M (2005) An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health & Quality of Life Outcomes 3:41CrossRef

42.

Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A et al (2002) Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychology & Psychotherapy: Theory, Research & Practice 75:165–176CrossRef

43.

Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30A:37–40PubMedCrossRef

44.

Osborne RH, Elsworth GR, Sprangers MAG, Oort FJ, Hopper JL (2004) The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women. Qual Life Res 13:91–206PubMedCrossRef

45.

Bjelland I, Dahl AA, Haug TT, Neckelmann D, Bjelland I, Dahl AA et al (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77PubMedCrossRef

46.

0Hall A, A'Hern R, Fallowfield L (1999) Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 35:79–85PubMedCrossRef

47.

Hopwood P, Howell A, Maguire P (1991) Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64:353–356PubMed

48.

Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30:37–40CrossRef

49.

Mitchell AJ. (2009). How Accurate is the HADS as a screen for emotional complications of cancer? A metaanalysis against robust psychiatric interviews. Paper presented at the International Psycho-Oncology Society (IPOS) 11th World Congress, Vienna, Austria

50.

Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

51.

Shacham S (1983) A shortened version of the Profile of Mood States. J Pers Assess 47(3):305–306PubMedCrossRef

52.

DiLorenzo TA, Bovbjerg DH, Montgomery GH, Valdimarsdottir H, Jacobsen PB (1999) The application of a shortened version of the Profile of Mood States in a sample of breast cancer chemotherapy patients. Br J Health Psychol 4:315–325CrossRef

53.

Curran SL, Andrykowski MA, Studts JL (1995) Short Form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess 7:80–83CrossRef

54.

Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psycho-oncol 11:273–281CrossRef

55.

Conerly RC, Baker F, Dye J, Douglas CY, Zabora J (2002) Measuring depression in African American cancer survivors: the reliability and validity of the Center for Epidemiologic Study-Depression (CES-D) Scale. J Health Psychol 7:107–114CrossRef

56.

Hopko DR, Bell JL, Armento MEA, Robertson SMC, Hunt MK, Wolf NJ et al (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26:31–51PubMedCrossRef

57.

Carpenter JS, Andrykowski MA, Wilson J, Hall LA, Rayens MK, Sachs B et al (1998) Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs 19:481–494PubMedCrossRef

58.

Stommel M, Given BA, Given CW, Kalaian HA, Schulz R, McCorkle R (1993) Gender bias in the measurement properties of the Center for Epidemiologic Studies Depression Scale (CES-D). Psychiatry Res 49:239–250PubMedCrossRef

59.

Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting psychologists, Palo Alto

60.

Lovibond P, Lovibond S (1995) The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 33(3):335–343PubMedCrossRef

61.

Beck AT, Guth D, Steer RA, Ball R (1997) Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 35:785–791PubMedCrossRef

62.

Speca M, Carlson LE, Goodey E, Angen M (2000) A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62:613–622PubMed

63.

Thomas BC, Bultz BD, Thomas BC, Bultz BD (2008) The future in psychosocial oncology: screening for emotional distress—the sixth vital sign. Future Oncol 4:779–784PubMedCrossRef

64.

McNair DM, Lorr M, Droppleman LF (1992) Manual for the Profile of Mood States (POMS): revised. Educational and Industrial Testing Service, San Diego

65.

Center for Epidemiologic Studies (1971) Center for Epidemiologic Studies Depression Scale (CES-D). National Institute of Mental Health, Rockville

66.

Beck AT, Steer RA, Brown GK (1996) BDI®-II Manual. The Psychological Corporation, San Antonio, Texas, USA

67.

McNair DM, Heuchert JWP (2003) Profile of Mood States technical update. MHS, North Tonawanda, NY

68.

Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scale. J Pers Soc Psychol 54:1063–1070PubMedCrossRef

69.

Derogatis LR et al (1974) SCL-90: an outpatient psychiatric rating scale. Preliminary report. Psychopharmacol Bull 9:13–28

70.

Veit CT, Ware JE (1983) The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 51:730–742

71.

Derogatis LR, Melisaratos N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13(3):595–605PubMedCrossRef

72.

Derogatis LR, Rutigliano PJ (1996) Derogatis Affects Balance Scale (DABS). In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadelphia

73.

Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82:1904–1908PubMedCrossRef

74.

Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMed

75.

Spitzer RL, Kroenke K, Williams JB (1999) Patient Health Questionnaire primary care study group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J Am Med Assoc 282:1737–1744CrossRef

76.

Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S (1987) A brief POMS measure of distress for cancer patients. J Chron Dis 40:939–942PubMedCrossRef

77.

Leckie MS, Thompson E (1979) Symptoms of Stress Inventory. University of Washington Serial (Book, Monograph), Seattle

78.

Carlson LE, Thomas BC (2007) Development of the Calgary Symptoms of Stress Inventory (C-SOSI). Int J Behav Med 14:249–256PubMedCrossRef

79.

Bradburn N (1969) The structure of psychological well-being. Aldine, Chicago

80.

Beck AT, Steer RA (1990) Manual for the Beck Anxiety Inventory. Psychological Corporation, San Antonio

81.

Lovibond SH, Lovibond PF (1993) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation, Sydney

82.

Goldberg D, Williams P (1988) A user's guide to the General Health Questionnaire (GHQ). GL Assessment, London

83.

Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49PubMedCrossRef

84.

Stewart AL, Hays RD, Ware JE (1988) The MOS short-form General Health Survey: reliability and validity in a patient population. Med Care 26:724PubMedCrossRef

85.

Carver CS, Pozo C, Harris SD, Noriega V, Scheier MF, Robinson DS et al (1993) How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol 65(2):375–390PubMedCrossRef

86.

Guadagnoli E, Mor V (1989) Measuring cancer patients' affect: revision and psychometric properties of the Profile of Mood States (POMS). Psychological Assessment: A Journal of Consulting and Clinical Psychology 1:150–154CrossRef

87.

Lorr M, McNair DM, Heuchert JWP (2003) Profile of Mood States Bi-polar supplement: POMS-Bi. MHS, North Tonawanda, NY

88.

Hickie IB, Davenport TA, Hadzi-Pavlovic D, Koschera A, Naismith SL, Scott EM et al (2001) Development of a simple screening tool for common mental disorders in general practice. Med J Aust 175:10–17 [see comment]

89.

Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757PubMedCrossRef

90.

Fitch MI, Osoba D, Iscoe N, Szalai JP (1995) Predicting psychological distress in patients with cancer: conceptual basis and reliability evaluation of a self-report questionnaire. Anticancer Res 15:1533–1542PubMed

91.

Zabora JR, Smith-Wilson R, Fetting JH, Enterline JP (1990) An efficient method for psychosocial screening of cancer patients. Psychosomatics 31:192–196PubMed

92.

Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ (1999) Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics 40:64–69PubMed

93.

Zabora J, BrintzenhofeSzoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C et al (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics: Journal of Consultation Liaison Psychiatry 42(3):241–246

94.

Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443PubMedCrossRef

95.

Mitchell AJ (2007) Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 25:4670–4681 [see comment]PubMedCrossRef

96.

Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A et al (2008) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psycho-oncol 17:538–547CrossRef

97.

Carroll BT, Kathol RG, Noyes R Jr, Wald TG, Clamon GH (1993) Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 15:69–74PubMedCrossRef

98.

Sellick SM, Edwardson AD (2007) Screening new cancer patients for psychological distress using the Hospital Anxiety and Depression Scale. Psycho-oncol 16(6):534–542CrossRef

99.

Walker J, Postma K, McHugh GS, Rush R, Coyle B, Strong V et al (2007) Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 63:83–91PubMedCrossRef

100.

Cull A, Gould A, House A, Smith A, Strong V, Velikova G et al (2001) Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 85:1842–1849PubMedCrossRef

101.

Love AW, Kissane DW, Bloch S, Clarke D (2002) Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z j psychiatry 36:246–250PubMedCrossRef

102.

Love AW, Grabsch B, Clarke DM, Bloch S, Kissane DW (2004) Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z j psychiatry 38:526–531PubMed

103.

Janda M, Obermair A, Cella D, Perrin LC, Nicklin JL, Ward BG et al (2005) The Functional Assessment of Cancer—Vulvar: reliability and validity. Gynecol Oncol 97:568–575PubMedCrossRef

104.

Wagner LI, Beaumont JL, Ding B, Malin J, Peterman A, Calhoun E et al (2008) Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N). Support Care Cancer 16:47–56PubMedCrossRef

105.

Boyes A, Girgis A, Zucca A, Lecathelinais C (2009) Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey. Med J Aust 190:S94–S98PubMed

106.

Manne S, Schnoll R (2001) Measuring cancer patients' psychological distress and well-being: a factor analytic assessment of the Mental Health Inventory. Psychol Assess 13:99–109PubMedCrossRef

107.

Clover K, Carter GL, Adams C, Hickie I, Davenport T (2009) Concurrent validity of the PSYCH-6, a very short scale for detecting anxiety and depression, among oncology outpatients. Aust NZ J Psychiatry 43:682–688CrossRef

108.

Cole BS (2005) Spiritually-focused psychotherapy for people diagnosed with cancer: A pilot outcome study. Ment health Relig Cult 8:217–226CrossRef

109.

Courneya KS, Friedenreich CM, Sela RA, Quinney HA, Rhodes RE, Handman M et al (2003) The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes. Psycho-oncol 12:357–374CrossRef

110.

Doorenbos A, Given B, Given C, Verbitsky N, Cimprich B, McCorkle R et al (2005) Reducing symptom limitations: a cognitive behavioral intervention randomized trial. Psycho-oncol 14:574–584CrossRef

111.

Downe-Wamboldt BL, Butler LJ, Melanson PM, Coulter LA, Singleton JF, Keefe JM et al (2007) The effects and expense of augmenting usual cancer clinic care with telephone problem-solving counseling. Cancer Nurs 30:441–453PubMedCrossRef

112.

Badger T, Segrin C, Meek P, Lopez AM, Bonham E, Sieger A et al (2005) Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life. Oncology Nursing Forum Online 32:273–279CrossRef

113.

Badger T, Segrin C, Dorros SM, Meek P, Lopez AM. (2007). Depression and anxiety in women with breast cancer and their partners. Nursing Research 56(1):44–53

114.

Stanton AL, Ganz PA, Kwan L, Meyerowitz BE, Bower JE, Krupnick JL et al (2005) Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol 23:6009–6018PubMedCrossRef

115.

Steel JL, Nadeau K, Olek M, Carr BI (2007) Preliminary results of an individually tailored psychosocial intervention for patients with advanced hepatobiliary carcinoma. J Psychosoc Oncol 25:19–42PubMedCrossRef

116.

Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A (2004) Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 100:2253–2260PubMedCrossRef

117.

Wilkinson SM, Love SB, Westcombe AM, Gambles MA, Burgess CC, Cargill A et al (2007) Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 25:532–539PubMedCrossRef

118.

Winzelberg AJ, Classen C, Alpers GW, Roberts H, Koopman C, Adams RE et al (2003) Evaluation of an internet support group for women with primary breast cancer. Cancer 97:1164–1173PubMedCrossRef

119.

Krischer MM, Xu P, Meade CD, Jacobsen PB, Krischer MM, Xu P et al (2007) Self-administered stress management training in patients undergoing radiotherapy. J Clin Oncol 25:4657–4662PubMedCrossRef

120.

Carmack Taylor CL, Demoor C, Smith MA, Dunn AL, Basen-Engquist K, Nielsen I et al (2006) Active for life after cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psycho-oncol 15:847–862CrossRef

121.

Dirksen SR, Epstein DR, Dirksen SR, Epstein DR (2008) Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 61:664–675PubMedCrossRef

122.

Giesler RB, Given B, Given CW, Rawl S, Monahan P, Burns D et al (2005) Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention. Cancer 104:752–762PubMedCrossRef

123.

Katz MR, Irish JC, Devins GM, Katz MR, Irish JC, Devins GM (2004) Development and pilot testing of a psychoeducational intervention for oral cancer patients. Psycho-oncol 13:642–653CrossRef

124.

McCorkle R, Dowd M, Ercolano E, Schulman-Green D, Williams AL, Siefert ML et al (2009) Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psycho-oncol 18:62–70CrossRef

125.

Lepore SJ, Helgeson VS, Eton DT, Schulz R (2003) Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol 22:443–452PubMedCrossRef

126.

Orringer JS, Fendrick AM, Trask PC, Bichakjian CK, Schwartz JL, Wang TS et al (2005) The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial. J Am Acad Dermatol 53:224–229PubMedCrossRef

127.

Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J et al (2003) Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psycho-oncol 12:532–546CrossRef

128.

Boyes A, Newell S, Girgis A, McElduff P, Sanson-Fisher R (2006) Does routine assessment and real-time feedback improve cancer patients' psychosocial well-being? Eur J Cancer Care 15:163–171CrossRef

129.

Kornblith AB, Dowell JM, Herndon JE, Engelman BJ, Bauer-Wu S, Small EJ et al (2006) Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study. Cancer 107:2706–2714, 2ndPubMedCrossRef

130.

Schofield P, Payne S. (2003). A pilot study into the use of a multisensory environment (Snoezelen) within a palliative day-care setting. International journal of palliative nursing 9(3):124–130

131.

Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA et al (2008) Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 26:4651–4658PubMedCrossRef

132.

Pitceathly C, Maguire P, Fletcher I, Parle M, Tomenson B, Creed F (2009) Can a brief psychological intervention prevent anxiety or depressive disorders in cancer patients? A randomised controlled trial. Ann Oncol 20:928–934PubMedCrossRef

133.

Savard J, Simard S, Giguere I, Ivers H, Morin CM, Maunsell E et al (2006) Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 4:219–237PubMedCrossRef

134.

Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A et al (2004) Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 90:314–320PubMedCrossRef

135.

Clark M, Isaacks-Downton G, Wells N, Redlin-Frazier S, Eck C, Hepworth JT et al (2006) Use of preferred music to reduce emotional distress and symptom activity during radiation therapy. J Music Ther 43:247–265PubMed

136.

Hanser SB, Bauer-Wu S, Kubicek L, Healey M, Manola J, Hernandez M et al (2006) Effects of a music therapy intervention on quality of life and distress in women with metastatic breast cancer. Journal Of The Society For Integrative Oncology 4:116–124PubMedCrossRef

137.

Allen SM, Shah AC, Nezu AM, Nezu CM, Ciambrone D, Hogan J et al (2002) A problem-solving approach to stress reduction among younger women with breast carcinoma: a randomized controlled trial. Cancer 94:3089–3100PubMedCrossRef

138.

Rosenbloom SK, David E, Victorson DE, Hahn EA, Peterman AH, Cella D (2007) Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psycho-oncol 16:1069–1079CrossRef

139.

Edmonds CVI, Lockwood GA, Cunningham AJ (1999) Psychological response to long term group therapy: a randomized trial with metastatic breast cancer patients. Psycho-oncol 8:74–91CrossRef

140.

Bailey DE, Mishel MH, Belyea M, Stewart JL, Mohler J, Bailey DE et al (2004) Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nurs 27:339–346PubMedCrossRef

141.

Lemieux J, Beaton DE, Hogg-Johnson S, Bordeleau LJ, Hunter J, Goodwin PJ (2007) Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer. Qual Life Res 16:1007–1017PubMedCrossRef

142.

Lemieux J, Beaton DE, Hogg-Johnson S, Bordeleau LJ, Goodwin PJ (2007) Three methods for minimally important difference: no relationship was found with the net proportion of patients improving. J Clin Epidemiol 60:448–455PubMedCrossRef

143.

Powell CB, Kneier A, Chen LM, Rubin M, Kronewetter C, Levine E et al (2008) A randomized study of the effectiveness of a brief psychosocial intervention for women attending a gynecologic cancer clinic. Gynecol Oncol 111:137–143PubMedCrossRef

144.

Sandgren AK, McCaul KD (2003) Short-term effects of telephone therapy for breast cancer patients. Health Psychol 22:310–315PubMedCrossRef

145.

Sandgren AK, McCaul KD, Sandgren AK, McCaul KD (2007) Long-term telephone therapy outcomes for breast cancer patients. Psycho-oncol 16:38–47CrossRef

146.

Culos-Reed SN, Carlson LE, Daroux LM, Hately-Aldous S (2006) A pilot study of yoga for breast cancer survivors: physical and psychological benefits. Psycho-oncol 15:891–897CrossRef

147.

Levine EG, Eckhardt J, Targ E (2005) Change in post-traumatic stress symptoms following psychosocial treatment for breast cancer. Psycho-oncol 14:618–635CrossRef

148.

Pinto BM, Clark MM, Maruyama NC, Feder SI, Pinto BM, Clark MM et al (2003) Psychological and fitness changes associated with exercise participation among women with breast cancer. Psycho-oncol 12:118–126CrossRef

149.

Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J et al (2008) Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 372:40–48 [see comment]PubMedCrossRef

150.

Monti DA, Peterson C, Kunkel EJ, Hauck WW, Pequignot E, Rhodes L et al (2006) A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psycho-oncol 15:363–373CrossRef

Titel: A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses
verfasst von: Tim Luckett
Phyllis N Butow
Madeleine T King
Mayumi Oguchi
Gaynor Heading
Nadine A Hackl
Nicole Rankin
Melanie A Price
Publikationsdatum: 01.10.2010
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 10/2010
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-0932-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses

Abstract

Objective

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2010

Accuracy of reporting current medications by cancer patients presenting to an emergency center

Determinants of complicated grief in caregivers who cared for terminal cancer patients

Improving sleep quality for cancer patients: benefits of a home-based exercise intervention

The ties that bind: a reflection on physician grief

Efficacy of multifaceted interventions in reducing complications of peripherally inserted central catheter in adult oncology patients

Response to “Spinal analgesia: where is the evidence?”

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie